The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss in older individuals worldwide. The disease is characterized by abnormal extracellular deposits, known as drusen, that accumulate along the basal surface of the retinal pigmented epithelium. Although drusen deposition is common in older individuals, large numbers of drusen and/or extensive areas of confluent drusen represent a significant risk factor for AMD. Widespread drusen deposition is associated with retinal pigmented epithelial cell dysfunction and degeneration of the photoreceptor cells of the neural retina. Recent studies have shown that drusen contain a variety of immunomodulatory molecules, suggesting that the process of drusen formation involves local inflammatory events, including activation of the complement cascade. Similar observations in Alzheimer's disease (AD) have lead to the hypothesis that chronic localized inflammation is an important element of AD pathogenesis, with significant neurodegenerative consequences. Accordingly, the amyloid beta (Aβ) peptide, a major constituent of neuritic plaques in AD, has been implicated as a primary activator of complement in AD. Here we show that Aβ is associated with a substructural vesicular component within drusen. Aβ colocalizes with activated complement components in these “amyloid vesicles,” thereby identifying them as potential primary sites of complement activation. Thus, Aβ deposition could be an important component of the local inflammatory events that contribute to atrophy of the retinal pigmented epithelium, drusen biogenesis, and the pathogenesis of AMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Complement components, other inflammatory molecules, lipids, lipoproteins B and E, and glycoproteins are common constituents of ocular drusen (Johnson et al., 2002).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Johnson et al., 2002
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Bustin, S. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250169 · Cited by 3,872
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
Self-citationA role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
Self-citationMullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
Self-citationNormal and Abnormal Biology of the beta-Amyloid Precursor Protein
Selkoe, D. J. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.002421 · Cited by 818
Complement activation by beta-amyloid in Alzheimer disease.
Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., & Ward, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10016 · Cited by 817
Johnson, L. V., Leitner, W. P., Staples, M. K., & Anderson, D. H. (2001) · Experimental Eye Research · doi:10.1006/exer.2001.1094 · Cited by 621
Self-citationAccumulation of cholesterol with age in human Bruch's membrane.
Curcio, C. A., Millican, C. L., Bailey, T. A., & Kruth, H. S. (2001) · PubMed · Cited by 508
Immune System Response in Alzheimer's Disease
McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029863 · Cited by 459
Research works printed but not linked: 9
- G S Hageman, P J Luthert, N H V Chong, L V Johnson, D H Anderson, R F Mullins Progr. Ret. Eye Res., eds N N Osborne, G J Chader (Elsevier Science, London) 20, 705–732 (2001).
- H Lin, D O Clegg Invest Ophthalmol Visual Sci 39, 1703–1712 (1998).
- K S Kim, D L Miller, V J Sapienza, C M J Chen, C Bai, I Grundke-Iqbal, J R Currie, H M Wisniewski Neurosci Res Comm 2, 121–130 (1988).
- K S Kim, G Y Wen, C Bancher, C M J Chen, V J Sapienza, H Hong, H M Wisniewski Neurosci Res Commun 7, 113–122 (1990).
- D A Simpson, S Feeney, C Boyle, A W Stitt Mol Vis 6, 178–183 (2000).
- C A Curcio, C L Millican, T Bailey, H S Kruth Invest Ophthalmol Visual Sci 42, 265–274 (2001).
- K Loeffler, D Edward, M Tso Invest Ophthalmol Visual Sci 36, 24–31 (1995).
- R P Burns, L Feeney-Burns Trans Am Ophthalmol Soc 78, 206–225 (1980).
- R J Ulshafer, C B Allen, B Nicolaissen, M L Rubin Invest Ophthalmol Visual Sci 28, 683–689 (1987).
Cited by
Items 301–400 of 495
Long-term treatment with anti-VEGF does not induce cell aging in primary retinal pigment epithelium
Schottler, J., Randoll, N., Lucius, R., Caliebe, A., Roider, J. B., & Klettner, A. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.03.002 · Cited by 17
Lê, J. T., Agrón, E., Keenan, T. D. L., Clemons, T. E., Brenowitz, W. D., Yaffe, K. S., & Chew, E. Y. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12473 · Cited by 17
Banevičius, M., Vilkevičiūtė, A., Kriaučiūnienė, L., Liutkevičienė, R., & Deltuva, V. P. (2018) · Medical Science Monitor · doi:10.12659/msm.905311 · Cited by 17
Genetic and Epigenetic Biomarkers Linking Alzheimer’s Disease and Age-Related Macular Degeneration
Kaštelan, S., Nikuševa-Martić, T., Pašalić, D., Antunica, A. G., & Zimak, D. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137271 · Cited by 17
Noh, S., Lee, S. J., Cho, C. S., Jo, D. H., Park, K., & Kim, J. H. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.12.012 · Cited by 17
Dai, B., Lei, C., Lin, R., Tao, L., Yue, B., Peng, H., & Lei, B. (2017) · Inflammation Research · doi:10.1007/s00011-017-1036-4 · Cited by 16
El‐Darzi, N., Mast, N., Buchner, D. A., Saadane, A., Dailey, B., Trichonas, G., & Pikuleva, I. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.902254 · Cited by 16
Lower cognitive function in patients with age-related macular degeneration: a meta-analysis
Dang, Y., Zhou, L., Sun, C.-L., Wei, L., Gu, Z., & Lv, L. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s102213 · Cited by 16
Boxerman, H., Wittich, W., & Overbury, O. (2014) · British Journal of Visual Impairment · doi:10.1177/0264619614557529 · Cited by 16
Wu, S., Zheng, F., Sui, A., Wu, D., & Chen, Z. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.110050 · Cited by 16
Central Nervous System Diseases and Inflammation
Tenner, A. J., & Pisalyaput, K. (2007) · Springer eBooks · doi:10.1007/978-0-387-73894-9_8 · Cited by 15
Kam, J. H., Morgan, J. E., & Jeffery, G. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.07.002 · Cited by 15
Rehan, S., Giroud, N., Al‐Yawer, F., Wittich, W., & Phillips, N. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201521 · Cited by 15
MINI-COGNITIVE TESTING IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION
Al-Salem, K. M., & Schaal, S. (2013) · Retina · doi:10.1097/iae.0000000000000006 · Cited by 14
Sun, C., Tikellis, G., Klein, R., Steffens, D. C., Larsen, E. K. M., & Wong, T. Y. (2007) · Ophthalmic Epidemiology · doi:10.1080/09286580601186742 · Cited by 14
Enfermedad de Alzheimer y degeneración macular asociada a la edad
Roca-Santiago, H. M., Lago-Bouza, J. R., Millán-Calentí, J. C., & Gómez-Ulla-Irazazábal, F. (2006) · Archivos de la Sociedad Española de Oftalmología · doi:10.4321/s0365-66912006000200006 · Cited by 14
Jo, D. H., Cho, C. S., Kim, J. H., & Kim, J. H. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.07.013 · Cited by 14
State-of-the art pharmacotherapy for non-neovascular age-related macular degeneration
Veritti, D., Sarao, V., Samassa, F., Danese, C., Löwenstein, A., Schmidt-Erfurth, U. M., & Lanzetta, P. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1736557 · Cited by 14
New Molecular Histopathologic Insights Into the Pathogenesis of Age-related Macular Degeneration
Handa, J. T. (2006) · International Ophthalmology Clinics · doi:10.1097/iio.0b013e31802bd546 · Cited by 14
Glycoproteins of drusen and drusen-like lesions
D’Souza, Y., Jones, C. J. P., & Bonshek, R. E. (2007) · Journal of Molecular Histology · doi:10.1007/s10735-007-9130-5 · Cited by 14
Vaccines for conformational disorders
Sadowski, M. J., & Wısnıewskı, T. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.3.279 · Cited by 14
Serum Leptin and Age-Related Macular Degeneration
Seshasai, S., Liao, J., Toh, Q. C., Cheng, C., Cheung, C. M. G., Sethi, S. K., Wong, T. Y., & Sabanayagam, C. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15933 · Cited by 15
Sant’Anna, R., Navarro, S., Ventura, S., Paraoan, L., & Foguel, D. (2016) · FEBS Letters · doi:10.1002/1873-3468.12093 · Cited by 14
Aging and neurogenesis, a lesion from Alzheimer's disease.
Taupin, P. (2010) · Europe PMC (PubMed Central) · Cited by 14
Therapeutic applications of chelating drugs in iron metabolic disorders of the brain and retina
Shahandeh, A., Bui, B. V., Finkelstein, D. I., & Nguyen, C. T. O. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24685 · Cited by 13
Kochounian, H., Johnson, L. V., & Fong, H. K. W. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.01.019 · Cited by 13
Self-citationFields, M. A., Cai, H., Bowrey, H. E., Moreira, E. F., Gooz, M. B., Kunchithapautham, K., Gong, J., Vought, E., & Priore, L. V. D. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16438 · Cited by 13
QUANTIFICATION OF FLUORESCEIN-STAINED DRUSEN ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION
Friedman, D. A., Parker, J. S., Kimble, J. A., Delori, F. C., McGwin, G., & Curcio, C. A. (2011) · Retina · doi:10.1097/iae.0b013e318219e5e9 · Cited by 13
Kim, J.-B., & Lad, E. M. (2020) · Drugs & Aging · doi:10.1007/s40266-020-00822-6 · Cited by 12
Lynn, S. A., Pandi, S. P. S., Sánchez‐Bretaño, A., Muir, A.-M., Parker, L., Chatelet, D. S., Newall, T., Scott, J. A., Keeling, E., Smyth, N. R., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01784-w · Cited by 12
Peiretti, E., Mandas, A., Abete, C., Vinci, M., Piludu, S., Casu, M., Caminiti, G., Dessì, S., & Fossarello, M. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.04.017 · Cited by 12
Inhibition of AMD-Like Pathology With a Neurotrophic Compound in Aged Rats and 3xTg-AD Mice
Liu, Y., Wei, W., Baazaoui, N., Liu, F., & Iqbal, K. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00309 · Cited by 12
Degeneración macular relacionada con la edad
Pardo, Í. C., Varona, D. G., & Remedios, D. I. D. M. (2008) · Revista Archivo Médico de Camagüey · Cited by 12
Rudolf, M., Seckerdieck, K., Grisanti, S., & Curcio, C. A. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-304226 · Cited by 12
Rinaldi, M., Pezone, A., Quadrini, G. I., Abbadessa, G., Laezza, M. P., Passaro, M. L., Porcellini, A., & Costagliola, C. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1371745 · Cited by 11
Melatonin and abeta, macular degeneration and alzheimers disease: same disease, different outcomes?
Bajić, V., & Panfoli, I. (2012) · Medical Hypothesis Discovery & Innovation in Ophthalmology · Cited by 11
Association of Anticholinergic Drug Use With Risk for Late Age-Related Macular Degeneration
Aldebert, G., Faillie, J., Hillaire‐Buys, D., Mura, T., Carrière, I., Delcourt, C., Creuzot-Garcher, C. P., Villain, M., & Daïen, V. (2018) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2018.1719 · Cited by 11
Aboelnour, A., Kam, J. H., Elnasharty, M., Sayed-Ahmed, A., & Jeffery, G. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.05.015 · Cited by 11
Hatef, E., Mohammadi, S.-F., Alinia, C., Ashrafi, E., Mohammadi, S.-M., Lashay, A., & Sadeghi-Tari, A. (2015) · Middle East African Journal of Ophthalmology · doi:10.4103/0974-9233.171781 · Cited by 11
Vujosevic, S., Limoli, C., & Kozak, I. (2024) · Eye · doi:10.1038/s41433-024-03341-5 · Cited by 10
Ong, J., Selvam, A., Driban, M., Zarnegar, A., Silva, S. I. M. M. A. D., Joy, J. G., Rossi, E. A., Geest, J. P. V., Sahel, J., & Chhablani, J. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101358 · Cited by 10
Corticosteroids and Anti-Complement Therapy in Retinal Diseases
Narayanan, R., & Kuppermann, B. D. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_22 · Cited by 10
Shoda, C., Kitagawa, Y., Shimada, H., Yuzawa, M., Tateno, A., & Okubo, Y. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170956 · Cited by 10
Tsao, S. W., Gabriel, R., Thaker, K., Kuppermann, B. D., & Kenney, M. C. (2018) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20180814-04 · Cited by 9
Pathogenesis of Age-Related Macular Degeneration
Zarbin, M. A. (2012) · ESASO course series · doi:10.1159/000336763 · Cited by 9
Smilnak, G., Deans, J. R., Doraiswamy, P. M., Stinnett, S. S., Whitson, H. E., & Lad, E. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223199 · Cited by 9
Novel immunological approaches for the treatment of Alzheimer's disease.
Sabharwal, P., & Wısnıewskı, T. (2014) · PubMed · doi:10.3969/j.issn.1672-6731.2014.03.001 · Cited by 9
Association between age-related macular degeneration and subjective cognitive complaints
Zhu, Z., Liao, H., Wang, W., Scheetz, J., Zhang, J., & He, M. (2019) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2019-314853 · Cited by 9
Pathobiology of the Outer Retina: Genetic and Nongenetic Causes of Disease
Haider, N. B., Cruz, N. M., Allocca, M., & Yuan, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.04706-7 · Cited by 9
Single‐cell RNA sequencing: A new opportunity for retinal research
You, M., Rong, R., Zeng, Z., Li, H., Xia, X., & Ji, D. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1652 · Cited by 9
Yu, S. S., Tang, X., Ho, J. Y. S., Chang, R. C., & Chiu, K. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00119 · Cited by 9
PPAR Nuclear Receptors and Altered RPE Lipid Metabolism in Age-Related Macular Degeneration
Malek, G., Hu, P., Wielgus, A. R., Dwyer, M. A., & Cousins, S. W. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1399-9_49 · Cited by 9
Borrie, S. C., Duggan, J., & Cordeiro, M. F. (2009) · Expert Review of Ophthalmology · doi:10.1586/17469899.4.1.27 · Cited by 8
(–)-Epicatechin Provides Neuroprotection in Sodium Iodate-Induced Retinal Degeneration
Peng, M., Zhou, X., Yao, F., Li, H., Song, W., Xiong, S., & Xia, X. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.879901 · Cited by 8
Apolipoprotein E ε4 offers protection against age-related macular degeneration
Friedman, D. A., Lukiw, W. J., & Hill, J. M. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.09.049 · Cited by 8
Petrukhin, K. E. (2020) · Topics in medicinal chemistry · doi:10.1007/7355_2020_105 · Cited by 7
Ratnayaka, J. A., & Lynn, S. A. (2016) · InTech eBooks · doi:10.5772/64790 · Cited by 7
Znaczenie cyklooksygenaz w neurotoksyczności peptydów amyloidu β w chorobie Alzheimera
Cąkała, M., & Strosznajder, J. B. (2010) · Neurologia i Neurochirurgia Polska · doi:10.1016/s0028-3843(14)60407-2 · Cited by 7
The Role of Amyloid-β in Retinal Degeneration
Bruban, J., Dinet, V., & Mascarelli, F. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0631-0_10 · Cited by 7
Stout, J. A., Mahzarnia, A., Dai, R., Anderson, R. J., Cousins, S. W., Zhuang, J., Lad, E. M., Whitaker, D., Madden, D. J., Potter, G. G., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12010147 · Cited by 7
Dong, Z., Li, J., Leng, Y., Sun, X., Hu, H., He, Y., Tan, Z., & Ge, J. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-34 · Cited by 7
López‐Cuenca, I., Salobrar‐García, E., Gil‐Salgado, I., Sánchez-Puebla, L., Elvira‐Hurtado, L., Fernández‐Albarral, J. A., Ramírez‐Toraño, F., Barabash, A., de Frutos‐Lucas, J., Salazar, J. J., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050847 · Cited by 7
Highly Expressed Amyloid Beta-42 Of Aqueous Humor In Patients With Neovascular Macular Degeneration
Zhu, J., Su, T., Wang, M., Li, M., Liu, L., & Wang, F. (2021) · Seminars in Ophthalmology · doi:10.1080/08820538.2021.1883679 · Cited by 6
Advances in Retinal Imaging: Retinal Amyloid Imaging
Koronyo‐Hamaoui, M., Doustar, J., Oviatt, M., Black, K. L., & Koronyo, Y. (2020) · Springer eBooks · doi:10.1007/978-3-030-26269-3_6 · Cited by 5
Novel drug development for geographic atrophy
Leung, H. Y. E., Zhang, J., Radke, N. V., Gan, S., Yao, S., Wang, Z., Li, J., Liu, X., Chong, V. N., Wang, X., et al. (2026) · Asia-Pacific Journal of Ophthalmology · doi:10.1016/j.apjo.2026.100305 · Cited by 5
The nuclear factor E2-related factor 2 and age-related macular degeneration
Torres, R. J. D. A., Torres, R. J. D. A., Luchini, A., & Ferreira, A. L. A. (2022) · Arquivos Brasileiros de Oftalmologia · doi:10.5935/0004-2749.20230024 · Cited by 5
Inflammation in age-related macular degeneration: pathological or physiological?
Yasukawa, T. (2009) · Expert Review of Ophthalmology · doi:10.1586/eop.09.1 · Cited by 5
Esteban, O., Marcuello, C., Martínez, M., Lavilla, L., Marco, S., & Ascaso, F. J. (2021) · Archivos de la Sociedad Española de Oftalmología (English Edition) · doi:10.1016/j.oftale.2021.01.002 · Cited by 5
Aged human iPSC-RPE organoid cultures display hallmarks of drusen formationPreprint
Mesch, L., Pashkovskaia, N., Cora, V., Pars, S., Corti, S., Cipriano, M., Loskill, P., Körtvely, E., Kustermann, S., Mesquida, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.12.463899 · Cited by 5
Chu, Z., Ma, G., Sun, X., Xu, Z., & Zhang, J. (2020) · Journal of Medicinal Food · doi:10.1089/jmf.2019.4558 · Cited by 5
Amyloid and Neurodegeneration: Alzheimer's Disease and Retinal Degeneration
Prakasam, A., Venugopal, C., Suram, A., Pacheco‐Quinto, J., Zhou, Y., Pappolla, M. A., Sharpe, K. A., Lahiri, D. K., Greig, N. H., Rohrer, B. ̈., et al. (2008) · Springer eBooks · doi:10.1007/978-0-387-30375-8_7 · Cited by 4
Alzheimer’s Disease: From Pathogenesis to Emerging Therapeutic Targets
Takahashi, T., & Muguruma, K. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15062357 · Cited by 4
Laser for Prevention of Choroidal Neovascularization
Luttrull, J. K., & Kent, D. L. (2020) · Springer eBooks · doi:10.1007/978-981-15-2213-0_30 · Cited by 4
Kent, D. L. (2015) · Eye · doi:10.1038/eye.2015.140 · Cited by 4
Animal Models for Age-Related Macular Degeneration
Hollyfield, J. G., & Kuttner-Kondo, L. A. (2009) · Neuromethods · doi:10.1007/978-1-60761-541-5_5 · Cited by 4
Son, K. Y., Choi, Y.-J., Kim, B., Han, K., Hwang, S., Jung, W., Shin, D. W., & Lim, D. H. (2024) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2024.105392 · Cited by 4
Neuroprotective Agents in Glaucoma
Bagli, E., & Kitsos, G. (2011) · InTech eBooks · doi:10.5772/19067 · Cited by 4
Anisetti, B., Stewart, M. W., Eggenberger, E., Shourav, M. M. I., Youssef, H., Elkhair, A. M., Ertekin‐Taner, N., Meschia, J. F., & Lin, M. (2023) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2023.107244 · Cited by 4
Lapchak, P. A., Butte, P. V., & Rajput, P. S. (2016) · Pan Stanford Publishing Pte. Ltd. eBooks · doi:10.1201/9781315364827-39 · Cited by 4
Retinal neuroprotection in dry age-related macular degeneration
Chinskey, N. D., Besirli, C. G., & Zacks, D. N. (2012) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2012.07.001 · Cited by 4
Hammond, B. R., & Renzi‐Hammond, L. M. (2016) · Advances in Nutrition · doi:10.3945/an.115.011866 · Cited by 3
Review of Emerging Treatments for Age-Related Macular Degeneration
Zarbin, M. A., & Rosenfeld, P. J. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-606-7_1 · Cited by 3
Harris, C., Nisar, M. A., Amamoo, R., Patel, R., Martin, P. M., Jadeja, R. N., & Thounaojam, M. C. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.111094 · Cited by 3
Malarte, M., Chiotis, K., Ioannou, K., & Rodriguez‐Vieitez, E. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70222 · Cited by 3
Apolipoproteins in Different Amyloidoses
Sadowski, M., & Wısnıewskı, T. (2007) · Springer eBooks · doi:10.1007/0-387-25919-8_6 · Cited by 3
Cuevas, P., Outeiriño, L. A., Azanza, C., Angulo, J. C., & Giménez‐Gallego, G. (2013) · Journal of Aging and Gerontology · doi:10.12974/2309-6128.2013.01.01.1 · Cited by 3
Recent Progress in Small-Molecule Agents Against Age-Related Macular Degeneration
Mogi, M., Adams, C. M., Ji, N., & Mainolfi, N. (2013) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-417150-3.00022-3 · Cited by 3
Ayala-Peña, V. B. (2025) · Viruses · doi:10.3390/v17081056 · Cited by 3
Murphy, C. E., Johnson, A. P., Koenekoop, R. K., Seiple, W., & Overbury, O. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.586691 · Cited by 3
Dietary fatty acids and lipoproteins on progression of age-related macular degeneration
la Paz, S. M., Naranjo, M. C., Bermúdez, B., López, S., Abia, R., & Muriana, F. J. G. (2017) · Grasas y Aceites · doi:10.3989/gya.0830162 · Cited by 3
Raudino, F. (2018) · Archives of Neuroscience · doi:10.5812/ans.74225 · Cited by 3
Establishing a human cell-based model system for macular degeneration
Neiteler, A. (2019) · ERA · doi:10.7488/era/8 · Cited by 3
Gastric emptying is involved inLactobacilluscolonisation in mouse stomach
Sahasakul, Y., Takemura, N., & Sonoyama, K. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514000968 · Cited by 3
Sambhariya, W. S., Rickman, C. B., D'Amore, P. A., Corradetti, G., Hageman, G. S., Howell, G. R., Marola, O. J., Phatnani, H. P., Philp, N. J., Sinha, D., et al. (2026) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2026.101449 · Cited by 2
Complement inhibitors for age-related macular degeneration
Williams, M. A., McKay, G. J., & Chakravarthy, U. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009300 · Cited by 2
Buchberger, A. M. S. (2016) · Figshare · Cited by 2
The Role of Inflammation in Age-Related Macular Degeneration
Harris, J. M., & Wu, D. M. (2025) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000578 · Cited by 2
Treatment Approaches for Dry AMD
Yehoshua, Z., & Rosenfeld, P. J. (2012) · Springer eBooks · doi:10.1007/978-3-642-22107-1_17 · Cited by 2
Function and pathology of the human retinal pigment epithelium
Booij, J. C. (2010) · UvA-DARE (University of Amsterdam) · Cited by 2
Metadata
- Authors
- Johnson, L. V., Leitner, W. P., Rivest, A. J., Staples, M. K., Radeke, M. J., & Anderson, D. H.
- Affiliations
- University of California, Santa Barbara (US)
- Johns Hopkins University (US)
- ORCID
- Radeke, Monte J.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-08-20
- Volume
- 99
- Issue
- 18
- Pages
- 11830-11835
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC129354
- OpenAlex
- W2003101845
- Cited by
- 447
- References
- 45
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 14 · 2023: 8 · 2022: 17 · 2021: 20 · 2020: 20 · 2019: 14 · 2018: 19 · 2017: 26 · 2016: 24 · 2015: 34 · 2014: 38 · 2013: 21 · 2012: 23
- FWCI
- 8.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (R01EY011521, EY 11-521, R01EY011527, EY11527)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Keywords
- amyloid-beta, complement activation, age-related macular degeneration, drusen, retinal pigment epithelium, neuroinflammation, retinal aging, neuritic plaques, complement proteins
- MeSH terms
- Aged, Aged, 80 and over, Aging, Base Sequence, Complement Activation, Humans, Immunohistochemistry, Macular Degeneration, Middle Aged, Polymerase Chain Reaction, Amyloid beta-Peptides, DNA Primers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.